Successful validation

Read more about the purpose and background of this validation in the news item Clinical validation.

The Activator has been shown to activate neutrophils during a 30-minute treatment in more than thirty volunteers. The activated neutrophils secrete substances from the vesicles (granules) in which they are stored. These substances fight viruses or bacteria and also start the rest of the immune response, as described on the product page How does it work?

Decrease in granule density in neutrophils

We measured that, on average, the density of the granules in the neutrophils decreased with the Activator treatment. And that shows that immune substances are secreted. The decrease is subtle, but statistically very clear and with high confidence (99.8%). It is also important that no volunteer reported any unpleasant experiences or negative side-effects.

Follow-up studies

The results show that treatment with low-frequency electromagnetic fields has an effect in humans. The results indicate then that a treatment with the Activator makes an infectious disease more mild, so there is less negative impact on health.

We are now planning further follow-up studies. One of these studies focuses on the effects of the treatment in people who suffer from recurrent cystitis caused by bacteria that are resistant to antibiotics.

Scientific publication

The results of our research will soon be published in a scientific journal.

Acknowledgment

We would like to thank all volunteers who participated for their contributions. The high reliability was partly determined by the large number of volunteers who participated, everyone was important.

The research was funded by ZonMW and carried out in the summer of 2021 at the Bernhoven hospital in Uden.